ECHAlliance adds Global Pharmaceutical and Life Sciences Partners to its Team

14th January 2021

ECHAlliance are delighted to welcome two additional experienced members to our Global Team, Peter Ward and Matthew Wintle.

“Peter and Mathew are well known as successful entrepreneurs in the Global Pharmaceutical, Life Sciences and Digital Health Sectors. They will enhance and expand the services we offer to our Members and our Global Community”, said Brian O’Connor, Chair of the ECHAlliance  

“We are delighted to be joining the European Connected Health Alliance to help identify opportunities and connect their members with the global pharmaceutical and life sciences industry. This will be particularly important as we collectively respond to the COVID pandemic and establish the future of digital health”, said Peter Ward & Matthew Wintle

                                            ­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­


Peter Ward

Peter is one of the most successful and admired digital healthcare entrepreneurs working in the international pharmaceutical, life sciences and global healthcare sectors. With over 25 years of experience, building market leading businesses that have designed award winning solutions across all aspects of science and healthcare including, scientific communities, patient support, healthcare outcomes and education and training.

Matthew Wintle

Matthew is an innovation focussed physician with international, cross-sector, experience in the research, development and commercialisation of biopharmaceuticals, novel technologies and digital infrastructure. In collaboration with Public, Private and 3rd Sector Stakeholders from high-middle- and low-income countries he has accelerated the development of tools that target infectious and non-communicable diseases, delivering four first-in-class medicines to patients with rare and common diseases. 

Recent posts